MTRG Projects
Find out more about consulting projects completed by the Medical Technology Research Group
We provide high quality consulting services to pharmaceutical companies and other organisations, collaborating with Market Access, HTA, Pricing, Policy and Government Affairs teams - Dr Jennifer Gill, Associate Director, MTRG
A collaborative value framework to assess Next-Generation Sequencing/Comprehensive Genomic Profiling diagnostic technologies
Ongoing
Client: Precision Cancer Consortium
The Burden of Diabetes in Greece and Options for Reform in Diabetes Management in the Greek Health Care System
March 2025
Client: Hellenic Association of Pharmaceutical Companies
Sustainable Healthcare Financing for SDG-3 in ASEAN-6
February 2024
Client: US-ASEAN Business Council
Determining the Benefits of Improving Secondary Prevention of Cardiovascular Disease
November 2023
Client: EFPIA Cardiovascular Health Platform
Population Health Management in England
October 2022
Client: Novartis
Outcomes in Autism
October 2022
Client: F. Hoffmann La Roche
Access to Medicines in Europe
November 2021
Client: MSD
Population Health and Virtual Care
June 2021
Client: Sanofi
Headroom for Innovation in Egypt and the Kingdom of Saudi Arabia
May 2021
Client: PhRMA
Severe Asthma
May 2021
Client: AstraZeneca
Predictive Analytic Tools and Value-Based Healthcare
February 2021
Client: Takeda
Indication-Based Pricing of Innovative Medicines
October 2020
Client: Novartis
Access to Personalised Oncology in Europe
November 2020
Client: EFPIA
Financing High-Cost Curative Therapies
October 2020
Client: Novartis
Latin American Health System Overview
August 2019
Client: F. Hoffmann La Roche
Pharmaceutical Policy in China
May 2019
Client: Gilead Sciences
The Use of Real World Evidence
November 2016 - December 2019
Client: F. Hoffmann La Roche
Pharmaceutical Pricing and Reimbursement in the Middle East and North Africa Region
November 2018
Client: PhRMA
Changing paradigms in the management of Multiple Sclerosis
November 2018
Client: F. Hoffmann La Roche
Accelerated Approval and Access Schemes - New Oncology Medicines
May 2017 – November 2019
Client: AstraZeneca
European survey on the use of Real World Evidence
January 2017 - May 2018
Client: F. Hoffmann La Roche
External Reference Pricing
January 2016 - November 2017
Client: Pfizer
Improving Outcomes for People with Multiple Sclerosis
October 2017
Client: F. Hoffmann La Roche
Improving Access to Contraception
September 2017
Client: Pfizer
Policy Options for strengthened EU cooperation on Health Technology Assessment (HTA)
August 2017
Client: European Commission